Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nortriptyline and Transdermal Nicotine for Smoking Cessation
NCT00018148Phase 2Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Apr 1998
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Tobacco Use Disorder (TUD) comparing Nortriptyline + Nicotine with Placebo + Nicotine (2 arms). Primary endpoint: Validated smoking cessation at 6 months. Started Apr 1998; status: completed.
02
Drugs
nortriptyline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00018148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00018148.